These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29040993)

  • 1. Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study.
    Ishikawa T; Imai M; Owaki T; Sato H; Nozawa Y; Sano T; Iwanaga A; Seki K; Honma T; Yoshida T; Kudo M
    Dig Dis; 2017; 35(6):598-601. PubMed ID: 29040993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
    PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T
    Oncology; 2019; 96(2):79-86. PubMed ID: 30293080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma.
    Ishikawa T; Abe S; Inoue R; Sugano T; Watanabe Y; Iwanaga A; Seki K; Honma T; Nemoto T; Takeda K; Yoshida T
    PLoS One; 2014; 9(7):e103009. PubMed ID: 25047920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
    Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Imai Y; Chikayama T; Nakazawa M; Watanabe K; Ando S; Mizuno Y; Yoshino K; Sugawara K; Hamaoka K; Fujimori K; Inao M; Nakayama N; Oka M; Nagoshi S; Mochida S
    J Gastroenterol; 2012 Feb; 47(2):179-86. PubMed ID: 21976133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Yoshimatsu R; Yamagami T; Ishikawa M; Kajiwara K; Aikata H; Chayama K; Awai K
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):865-74. PubMed ID: 26711803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
    Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.
    Kora S; Urakawa H; Mitsufuji T; Osame A; Higashihara H; Yoshimitsu K
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1023-9. PubMed ID: 23238851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.
    Kim EH; Oh JS; Chun HJ; Choi BG; Lee HG
    Diagn Interv Radiol; 2018 Sep; 24(5):262-267. PubMed ID: 30211679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
    Irie T; Kuramochi M; Takahashi N
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cone-beam computed tomography during transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Miyayama S; Yamashiro M; Hattori Y; Orito N; Matsui K; Tsuji K; Yoshida M; Matsui O
    Jpn J Radiol; 2011 Jul; 29(6):371-7. PubMed ID: 21786092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Pung L; Ahmad M; Mueller K; Rosenberg J; Stave C; Hwang GL; Shah R; Kothary N
    J Vasc Interv Radiol; 2017 Mar; 28(3):334-341. PubMed ID: 28109724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery.
    Sugihara F; Murata S; Ueda T; Yasui D; Yamaguchi H; Miki I; Kawamoto C; Uchida E; Kumita SI
    Eur Radiol; 2017 Jun; 27(6):2474-2481. PubMed ID: 27678134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
    Okimoto K; Ogasawara S; Chiba T; Ooka Y; Oobu M; Azemoto R; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Yoshikawa M; Yokosuka O
    Anticancer Res; 2013 Dec; 33(12):5603-9. PubMed ID: 24324105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC.
    Iezzi R; Posa A; Tanzilli A; Carchesio F; Pompili M; Manfredi R
    Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1702-1707. PubMed ID: 32676963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
    Loffroy R; Lin M; Yenokyan G; Rao PP; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Liapi E; Geschwind JF
    Radiology; 2013 Feb; 266(2):636-48. PubMed ID: 23143027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of cone-beam computed tomography during chemoembolization of hepatocellular carcinomas fed exclusively by the cystic artery.
    Kinoshita M; Takechi K; Iwamoto S; Takao S; Shirono R; Harada M
    Jpn J Radiol; 2016 Nov; 34(11):747-753. PubMed ID: 27653751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.